No association of anti-GM1 and anti-GAD antibodies with juvenile myoclonic epilepsy: A pilot study

Aykutlu E., Baykan B., Gurses C., Gokyigit A., Saruhan-Direskeneli G.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, cilt.14, sa.5, ss.362-366, 2005 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 14 Sayı: 5
  • Basım Tarihi: 2005
  • Doi Numarası: 10.1016/j.seizure.2005.04.009
  • Dergi Adı: SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.362-366
  • İstanbul Üniversitesi Adresli: Evet

Özet

Purpose: The presence of anti-ganglioside (GM1) or anti-glutamic acid decarboxylase (GAD) antibodies has been reported in association with therapy-resistant epilepsy mostly of focal origin. Our aim was to detect GM1 and GAD autoantibodies in patients with juvenile myoclonic epilepsy (JME) and to evaluate their association with rarely encountered therapy-resistant cases in this idiopathic generalised epilepsy syndrome.